Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
DAA treatment reduces the risk of death and liver cancer in people with hepatitis C

Treatment with direct-acting antivirals (DAAs) reduced the risk of death, liver cancer and death from liver-related causes in French people with hepatitis C, according to

Published
13 February 2019
By
Keith Alcorn
Low testosterone persists after HCV clearance

Low levels of free testosterone are common among men with chronic hepatitis C infection following SVR and persist after HCV clearance, according to findings from a prospective, longitudinal cohort study.

Published
12 February 2019
From
Healio
Smoking, cholesterol, blood pressure are more important causes of disease than HIV in people living with HIV

Preventing smoking, lowering cholesterol, controlling blood pressure and curing hepatitis C would greatly reduce the burden of heart attacks, non-AIDS cancers and end-stage liver disease and kidney

Published
11 February 2019
By
Keith Alcorn
Tackling HIV and hepatitis C in Europe: towards minimum standards

Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form

Published
08 February 2019
By
Gus Cairns
Hepatitis C Fight Hinges on Prisons

Lawsuits across the country are seeking better but more expensive care for inmates with the infectious disease, who can spread it upon their release.

Published
05 February 2019
From
U.S. News & World Report
England: Countdown to hep C eradication

NHS England’s target date to eliminate hepatitis C is now just six years away. DDN hears what progress has been made, and what’s left to achieve, at the LJWG on Substance Use and Hepatitis C annual conference.

Published
05 February 2019
From
Drink & Drug News
HIV infection an independent risk factor for poorer survival from liver cancer

Infection with HIV is associated with significantly worse survival for people with hepatocellular carcinoma (HCC, the most common type of primary liver cancer), according to findings from a

Published
01 February 2019
By
Michael Carter
Non-alcoholic fatty liver disease: a growing health problem in people with HIV

Non-alcoholic fatty liver disease (NAFLD) is a major emerging health challenge for people living with HIV, according to a review of evidence by doctors from the University

Published
29 January 2019
By
Keith Alcorn
UK court dismisses AbbVie's legal challenge against the NHS

The High Court has dismissed a legal challenge by US pharmaceutical firm AbbVie against the National Health Service (NHS) England's procurement deal for drugs to treat and cure hepatitis C. The decision means that the plan to eliminate the virus in England remains on track.

Published
25 January 2019
From
The Lancet (free registration required)
Needle and syringe programs cost-effectively prevent hepatitis C transmission

Providing clean injecting equipment through needle and syringe programs is a highly cost-effective way of preventing hepatitis C (HCV) transmission among people who inject drugs and could save millions of pounds in infection treatment costs in the UK, according to research led by the University of Bristol and London School of Hygiene & Tropical Medicine.

Published
24 January 2019
From
Eurekalert Medicine & Health

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.